top of page

Medical Device Intellectual Property

experienced U.S. patent counsel for medical device innovators

AddyHart works with medical device companies, digital health innovators, universities, and emerging technology companies to protect innovations in the United States. Combining extensive patent prosecution experience with a deep understanding of FDA regulatory considerations, our attorneys help clients build patent portfolios that support product development, regulatory strategy, and successful commercialization.

FDA & Patent Strategy

Medical device innovation often sits at the intersection of patent protection, FDA regulation, software, artificial intelligence, and commercialization strategy. Brandon Theiss is a co-author of FDA and Intellectual Property Strategies for Medical Device Technologies, including both the first and second editions.

 

Read more about the book and Brandon’s insights on developing IP strategies for regulated medical device technologies.

image.png

Available Online

First Edition

image_edited.jpg

Available Online

Second Edition

Patent Prosecution for Medical Devices

Medical device patents require careful coordination between technical innovation, regulatory considerations, and long-term commercial objectives. We work with clients to develop patent applications and prosecution strategies designed to protect core technologies while supporting future product development and commercialization.

Related Publications & Insights

PTAB Memo Recenters Discretion On US Manufacturing

Law360

A Fed. Circ. Blueprint For Drafting Medical Device Patents

Law360

How Patent Eligibility Declarations Can Stave Off Rejection

Law360

Including a Description of Technical Advantages During Patent Application Drafting May Help Patent Eligibility

Intellectual Property Law Section Proceedings

Related Divergent IP Blog Articles

Reframing Patent Eligibility: U.S. § 101 Case Law Through the Lens of Japanese Technicality Doctrine

Brandon Theiss

image.png
Cross-Agency Candor: Managing FDA-USPTO Consistency to Avoid Inequitable Conduct and Regulatory Exposure

Brandon Theiss

AdobeStock_268648616_edited.jpg
bottom of page